AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

Azelis Group NV

Major Shareholding Notification Nov 19, 2025

3909_mrq_2025-11-19_4d017080-7df7-458e-b0e8-705404817850.pdf

Major Shareholding Notification

Open in Viewer

Opens in native device viewer

Azelis news release REGULATED INFORMATION

19 November 2025

Transparency notification from UBS Group AG

Antwerp (Belgium), 19 November 2025 – 17:48 CET – In accordance with Article 14 of the Belgian Transparency law of 2 May 2007, Azelis Group NV announces that on 18 November 2025, it has received a transparency notification from UBS Group AG.

1. Summary of the notification

On 12 November 2025, UBS Group AG (taking into account the holding of all its affiliates) owned 993,365 shares with voting rights, representing 0.41% of the total number of shares issued by the company (243,921,719), as well as 10,718,325 equivalent financial instruments, representing 4.39% of the voting rights issued by the company.

2. Content of the notification

Reason for the notification

Acquisition or disposal of voting securities or voting rights

Notification by

A parent undertaking or a controlling person

Persons subject to the notification requirement

Name Address (for legal entities)
UBS Group AG Bahnhofstrasse 45, 8001 Zürich

Date on which the threshold is crossed

12 November 2025

Threshold that is crossed (in %)

3%

Denominator

Notified Details

A) Voting rights Previous
notification
After the transaction
# of voting rights # of voting rights % of voting rights
Holders of voting rights Linked to
securities
Not linked to
the securities
Linked to
securities
Not linked
to the
securities
UBS Group AG 0 0 0.00% 0.00%
UBS AG 59,806 0 0.02% 0.00%
UBS Europe SE 18,286 0 0.01% 0.00%
UBS Switzerland AG 655,289 0 0.27% 0.00%
UBS Asset Management (Europe)
S.A.
80,518 0 0.03% 0.00%
UBS Asset Management Life
Limited
8,128 0 0.00% 0.00%
UBS Fund Management (Ireland)
Ltd.
72 0 0.00% 0.00%
UBS Fund Management
(Switzerland) AG
171,266 0 0.07% 0.00%
Subtotal 993,365 0.41%
TOTAL 993,365 0 0.41% 0.00%
B) Equivalent financial
instruments
After the transaction
Holders of equivalent
financial instruments
Type of financial
instrument
Expiration
date
Exercise
period
or date
# of voting
rights that may
be acquired if
the instrument
is exercised
% of voting
rights
Settlement
UBS AG Long Call Option 17/12/2027 177,000 0.07% physical
UBS AG Short Put Option 19/12/2025 500,000 0.20% physical

UBS AG Equity Swaps 28/03/2028 1,938 0.00% cash
UBS AG Right to Recall of Lent shares At any
time
257,118 0.11% physical
UBS AG Right to Substitute
shares delivered as
collaterals
At any
time
154,759 0.06% physical
UBS Switzerland AG Right to Recall of Lent shares At any
time
64,793 0.03% physical
UBS Switzerland AG Right to Substitute
shares delivered as
collaterals
At any
time
155,218 0.06% physical
UBS Switzerland AG Right of use over shares At any
time
7,446,832 3.05% physical
UBS AG Right of use over shares At any
time
1,224,167 0.50% physical
UBS Securities LLC Right of use over shares At any
time
675,000 0.28% physical
UBS AG Long Call Option 17/03/2028 61,500 0.03% physical
TOTAL 10,718,325 4.39%
TOTAL (A & B) # of voting rights % of voting rights
CALCULATE 11,711,690 4.80%

Chain of controlled undertakings through which the holding is effectively held, if applicable

Please see full chain of control attached.

Additional information

The disclosure obligation arose due to the total indirect holdings of UBS Group AG in voting rights of Azelis Group NV, held directly by controlled undertakings, going above 3% on 12th November 2025.

3. Further information

The full transparency notification as well as this press release can be consulted on the Azelis Group NV's website.

Contact information:

Azelis

[email protected]

About Azelis

Azelis is the reference global innovation service provider in the speciality chemical and food ingredients industry present in 65 countries across the globe with over 4,300 employees. Our knowledgeable teams of industry, market and technical experts are each dedicated to a specific market within Life Sciences and Industrial Chemicals. We offer a lateral value chain of complementary products to more than 62,000 customers, supported by +2,800 principal relationships, creating a turnover of €4.2 billion (2024). Azelis Group NV is listed on Euronext Brussels under ticker AZE and is included in the BEL20 and BEL®ESG indices.

Across our extensive network of more than 70 application laboratories, our award-winning teams help develop formulations and provide technical guidance throughout the customers' product development process. We combine a global market reach with a local footprint to offer a reliable, integrated, and unique digital service to local customers and attractive business opportunities to principals. Top industry-rated by Sustainalytics, Azelis is a leader in sustainability. We believe in building and nurturing solid, honest, and transparent relationships with our people and partners.

Impact through ideas. Innovation through formulation.

www.azelis.com

11. Information in relation to the person subject to the notification obligation – organizational chart
UBS Group AG
UBS AG
UBS Switzerland AG
-
UBS Group AG
UBS AG
UBS Europe SE
-
UBS Group AG
UBS AG
UBS Asset Management AG
UBS Asset Management (Europe) S.A.
-
UBS Group AG
UBS AG
UBS Asset Management AG
UBS Asset Management Holding (No. 2) Ltd
UBS Asset Management Holding Ltd
UBS Asset Management Life Ltd
-
UBS Group AG
UBS AG
UBS Fund Management (Ireland) Ltd.
-
UBS Group AG
UBS AG
UBS Asset Management AG
UBS Asset Management Switzerland AG
UBS Fund Management (Switzerland) AG
-
UBS Group AG
UBS AG
UBS Americas Holding LLC
UBS Americas Inc.
UBS Securities LLC

Talk to a Data Expert

Have a question? We'll get back to you promptly.